MAPKAPK2, a potential dynamic network biomarker of α-synuclein prior to its aggregation in PD patients

One of the important pathological features of Parkinson’s disease (PD) is the pathological aggregation of α-synuclein (α-Syn) in the substantia nigra. Preventing the aggregation of α-Syn has become a potential strategy for treating PD. However, the molecular mechanism of α-Syn aggregation is unclear...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Zhenggang, Li, Jiabao, Zhong, Jiayuan, Huang, Yilin, Hu, Jiaqi, Zhang, Piao, Zhang, Baowen, Jin, Yabin, Luo, Wei, Liu, Rui, Zhang, Yuhu, Ling, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020541/
https://www.ncbi.nlm.nih.gov/pubmed/36927756
http://dx.doi.org/10.1038/s41531-023-00479-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020541/
https://www.ncbi.nlm.nih.gov/pubmed/36927756
http://dx.doi.org/10.1038/s41531-023-00479-z

Ejemplares similares